LIST OF TABLES
TABLE 01. ASEAN BIOSIMILARS MARKET, BY COUNTRY, 20172025 ($MILLION)
TABLE 02. OFF GOING PATENTS 2013-2016
TABLE 03. ASEAN BIOSIMILARS MARKET, BY MOLECULE TYPE, 20172025 ($MILLION)
TABLE 04. CHINA BIOSIMILARS MARKET, BY MOLECULE TYPE, 20172025 ($MILLION)
TABLE 05. ASEAN AND CHINA BIOSIMILARS MARKET, BY MOLECULE TYPE, 20172025 ($MILLION)
TABLE 06. BIOSIMILARS MARKET FOR HUMAN GROWTH HORMONE, BY REGION, 20172025 ($MILLION)
TABLE 07. BIOSIMILARS MARKET FOR ERYTHROPOIETIN, BY REGION, 20172025 ($MILLION)
TABLE 08. MONOCLONAL ANTIBODIES FROM COMPANEIS IN CHINA
TABLE 09. BIOSIMILARS MARKET FOR MONOCLONAL ANTIBODIES, BY REGION, 20172025 ($MILLION)
TABLE 10. PREVALENCE OF DIABETES IN CHINA AND ASEAN COUNTRIES
TABLE 11. BIOSIMILARS MARKET FOR INSULIN, BY REGION, 20172025 ($MILLION)
TABLE 12. BIOSIMILARS MARKET FOR INTERFERON, BY REGION, 20172025 ($MILLION)
TABLE 13. BIOSIMILARS MARKET FOR GRANULOCYTE-COLONY STIMULATING FACTOR, BY REGION, 20172025 ($MILLION)
TABLE 14. BIOSIMILARS MARKET FOR PEPTIDE, BY REGION, 20172025 ($MILLION)
TABLE 15. ASEAN BIOSIMILARS MARKET, BY APPLICATION, 20172025 ($MILLION)
TABLE 16. CHINA BIOSIMILARS MARKET, BY APPLICATION, 20172025 ($MILLION)
TABLE 17. ASEAN AND CHINA BIOSIMILARS MARKET, BY APPLICATION, 20172025 ($MILLION)
TABLE 18. BIOSIMILARS MARKET FOR BLOOD DISORDERS, BY REGION, 20172025 ($MILLION)
TABLE 19. BIOSIMILARS MARKET FOR ONCOLOGY DISEASES, BY REGION, 20172025 ($MILLION)
TABLE 20. BIOSIMILARS MARKET FOR CHRONIC AND AUTOIMMUNE DISEASES, BY REGION, 20172025 ($MILLION)
TABLE 21. BIOSIMILARS MARKET FOR RHEUMATOID ARTHRITIS (RA), BY REGION, 20172025 ($MILLION)
TABLE 22. BIOSIMILARS MARKET FOR DIABETES, BY REGION, 20172025 ($MILLION)
TABLE 23. BIOSIMILARS MARKET FOR GLAUCOMA, BY REGION, 20172025 ($MILLION)
TABLE 24. BIOSIMILARS MARKET FOR OTHERS, BY REGION, 20172025 ($MILLION)
TABLE 25. BIOSIMILARS MARKET FOR GROWTH HORMONE DEFICIENCY, BY REGION, 20172025 ($MILLION)
TABLE 26. BIOSIMILARS MARKET FOR OTHERS, BY REGION, 20172025 ($MILLION)
TABLE 27. 3SBIO: COMPANY SNAPSHOT
TABLE 28. 3SBIO: APPLICATION PORTFOLIO
TABLE 29. QILU: COMPANY SNAPSHOT
TABLE 30. SANDOZ: COMPANY SNAPSHOT
TABLE 31. NOVARTIS: OPERATING SEGMENTS
TABLE 32. NOVARTIS AG: PRODUCT PORTFOLIO
TABLE 33. PFIZER: COMPANY SNAPSHOT
TABLE 34. PFIZER: OPERATING SEGMENTS
TABLE 35. PFIZER: PRODUCT PORTFOLIO
TABLE 36. STADA: COMPANY SNAPSHOT
TABLE 37. STADA: OPERATING SEGMENTS
TABLE 38. STADA: PRODUCT PORTFOLIO
TABLE 39. BEIJING SL: COMPANY SNAPSHOT
TABLE 40. BEIJING SL: OPERATING SEGMENTS
TABLE 41. BEIJING SL: PRODUCT PORTFOLIO
TABLE 42. FOSUN PHARMACEUTICAL: COMPANY SNAPSHOT
TABLE 43. FOSUN PHARMACEUTICAL: OPERATING SEGMENTS
TABLE 44. FOSUN PHARMACEUTICAL: PIPELINE PRODUCT PORTFOLIO
TABLE 45. AMGEN: COMPANY SNAPSHOT
TABLE 46. AMGEN: PRODUCT PORTFOLIO
TABLE 47. ASTRAZENECA: COMPANY SNAPSHOT
TABLE 48. ASTRAZENECA: OPERATING SEGMENTS
TABLE 49. ASTRAZENECA: PRODUCT PORTFOLIO
TABLE 50. TEVA: COMPANY SNAPSHOT
TABLE 51. TEVA: OPERATING SEGMENTS
TABLE 52. TEVA: PIPELINE PRODUCT PORTFOLIO LIST OF FIGURES
FIGURE 01. ASEAN AND CHINA MARKET SEGMENTATION
FIGURE 02. TOP WINNING STRATEGIES, BY YEAR, 2015-2018*
FIGURE 03. TOP WINNING STRATEGIES, BY DEVELOPMENT, 2015-2018* (%)
FIGURE 04. TOP WINNING STRATEGIES, BY COMPANY, 2015-2018*
FIGURE 05. MODERATE BARGAINING POWER OF SUPPLIERS
FIGURE 06. MODERATE BARGAINING POWER OF BUYERS
FIGURE 07. LOW THREAT OF SUBSTITUTION
FIGURE 08. MODERATE THREAT OF NEW ENTRANT
FIGURE 09. MODERATE COMPETITIVE RIVALRY
FIGURE 10. ASEAN BIOSIMILARS MARKET, 20172025 ($MILLION)
FIGURE 11. CHINA BIOSIMILARS MARKET, 20172025 ($MILLION)
FIGURE 12. ASEAN AND CHINA BIOSIMILARS MARKET: RESTRAINTS, DRIVERS, AND OPPORTUNITY
FIGURE 13. 3SBIO, 20152017 ($MILLION)
FIGURE 14. NOVARTIS: NET SALES, 20152017 ($MILLION)
FIGURE 15. NOVARTIS: REVENUE SHARE BY SEGMENT, 2017 (%)
FIGURE 16. NOVARTIS: REVENUE SHARE BY GEOGRAPHY, 2017 (%)
FIGURE 17. PFIZER: NET SALES, 20152017 ($MILLION)
FIGURE 18. PFIZER: REVENUE SHARE BY SEGMENT, 2017 (%)
FIGURE 19. PFIZER: REVENUE SHARE BY GEOGRAPHY, 2017 (%)
FIGURE 20. STADA: NET SALES, 20152017 ($MILLION)
FIGURE 21. STADA: REVENUE SHARE BY SEGMENT, 2017 (%)
FIGURE 22. STADA: REVENUE SHARE BY GEOGRAPHY, 2017 (%)
FIGURE 23. FOSUN PHARMACEUTICAL: NET SALES, 20152017 ($MILLION)
FIGURE 24. FOSUN PHARMACEUTICAL: REVENUE SHARE BY SEGMENT, 2017 (%)
FIGURE 25. FOSUN PHARMACEUTICAL: REVENUE SHARE BY GEOGRAPHY, 2017 (%)
FIGURE 26. AMGEN: NET SALES, 20152017 ($MILLION)
FIGURE 27. AMGEN: REVENUE SHARE BY PRODUCT, 2017 (%)
FIGURE 28. AMGEN: REVENUE SHARE BY GEOGRAPHY, 2017 (%)
FIGURE 29. ASTRAZENECA: REVENUE, 20152017 ($MILLION)
FIGURE 30. ASTRAZENECA: REVENUE SHARE BY GEOGRAPHY, 2017 (%)
FIGURE 31. TEVA: NET SALES, 20152017 ($MILLION)
FIGURE 32. TEVA: REVENUE SHARE BY SEGMENT, 2017 (%)
FIGURE 33. TEVA: REVENUE SHARE BY GEOGRAPHY, 2017 (%